Sosei Subsidiary Heptares, AstraZeneca Announce Agreement to Develop Novel Immuno-Oncology Treatments for Range of Cancers

Sosei Group Corporation (OTC: SOLTF) is pleased to announce that its wholly-owned subsidiary Heptares Therapeutics ...